Hillsborough, CA, United States of America

Steven Shak

This inventor holds 24 USPTO granted patents and 16 published patent applications, plus 11 CIPO patents and 17 EPO patents, primarily in Gene Expression Profiling. Top assignees: Genomic Health, Inc., Nsabp Foundation, Inc., Bristol-Myers Squibb Compnay. Active years: 2006-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven Shak. Retrieved from https://idiyas.com/inventor/steven-shak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 24 (Patent Applications = 16)

% Patents Active = 95.8

CIPO Patents = 11 (Patent Applications = 9)

EPO Patents = 17 (Patent Applications = 21)

Average Co-Inventor Count = 4.8

ph-index = 9

Forward Citations = 346(Granted Patents)

Company Filing History:

Nsabp Foundation, Inc.

patents

1 out of 3,745

Bristol-Myers Squibb Compnay

patents

4. 1 out of 1

Instituto Nazionale Tumori

patent

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

Areas of Expertise:

Gene Expression

Cancer Prognosis

Recurrence Prediction

Breast Cancer

Kidney Cancer

Prostate Cancer

Colorectal Cancer

Chemotherapy Response

EGFR Inhibitors

Molecular Indicators

Expression Profile

Prediction Algorithms

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12412642 - Method to use gene expression to determine likelihood of clinical outcome of renal cancer (2025-09-09),

2. 11776664 - Method to use gene expression to determine likelihood of clinical outcome of renal cancer (2023-10-03),

3. 11551782 - Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancer (2023-01-10),

4. 11220715 - Gene expression markers for breast cancer prognosis (2022-01-11),

5. 11011252 - Gene expression profile algorithm and test for determining prognosis of prostate cancer (2021-05-18),

6. 10892038 - Method to use gene expression to determine likelihood of clinical outcome of renal cancer (2021-01-12),

7. 10619215 - Prediction of likelihood of cancer recurrence (2020-04-14),

8. 10260104 - Method for using gene expression to determine prognosis of prostate cancer (2019-04-16),

9. 10181008 - Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancer (2019-01-15),

10. 10179936 - Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer and response to chemotherapy (2019-01-15),

11. 9944990 - Gene expression markers for breast cancer prognosis (2018-04-17),

12. 9605318 - Gene expression markers for predicting response to chemotherapy (2017-03-28),

13. 9551034 - Method to use gene expression to determine likelihood of clinical outcome of renal cancer (2017-01-24),

14. 8868352 - Predicting response to chemotherapy using gene expression markers (2014-10-21),

15. 8273534 - Predictors of patient response to treatment with EGF receptor inhibitors (2012-09-25),

Title: The Innovative Journey of Steven Shak

Introduction: Steven Shak, a renowned inventor hailing from Hillsborough, CA, has made significant contributions to the field of biotechnology with his groundbreaking innovations.

Latest Patents: Steven Shak holds several patents in the field of medical diagnostics, including a recent patent for a novel cancer detection technology that has revolutionized early diagnosis methods.

Career Highlights: With a career spanning over two decades, Steven Shak has worked tirelessly to bridge the gap between technology and healthcare, leading to the development of cutting-edge diagnostic tools that have saved countless lives.

Collaborations: Throughout his career, Steven Shak has collaborated with leading research institutions, universities, and biotech companies to further advance his inventions and bring them to the market, solidifying his reputation as a pioneer in the industry.

Conclusion: Steven Shak's passion for innovation and his dedication to improving healthcare through technology have cemented his legacy as a visionary inventor in the field of biotechnology.

Profile summary based on public USPTO records.